logo

For the Inventor, By the Inventor

Cleveland, OH, United States of America

Monica M Montano

This inventor holds 5 USPTO granted patents and 2 published patent applications. Top assignees: Case Western Reserve University, Cleveland State University, Other. Active years: 2004-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Monica M Montano. Retrieved from https://idiyas.com/inventor/monica-m-montano

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 5 

% Patents Active = 60.0

Average Co-Inventor Count = 2.0

ph-index = 2

Forward Citations = 4(Granted Patents)


Location History:

  • Shaker Heights, OH (US) (2004 - 2011)
  • Cleveland, OH (US) (2021 - 2023)

Company Filing History:

goldMedal4 out of 1,368 
 
Case Western Reserve University
 patents
silverMedal1 out of 79 
 
Cleveland State University
 patents
bronzeMedal1 out of 834,570 
Other
 patents
where one patent can have more than one assignee

Years Active: 2004-2023

Loading Chart...
5 patents (USPTO):Explore Patents
1. 11833124 - Compositions and methods for modulating HEXIM1 expression (2023-12-05),
2. 10959966 - Compositions and methods for modulating HEXM1 expression (2021-03-30),
3. 7888463 - Modulators of antiestrogen pharmacology (2011-02-15),
4. 7459543 - Modulators of antiestrogen pharmacology (2008-12-02),
5. 6753418 - Suppressors of human breast cancer cell growth (2004-06-22),

Title: Monica M Montano: Innovator in HEXIM1 Expression Modulation

Introduction

Monica M Montano is a prominent inventor based in Cleveland, OH (US). She has made significant contributions to the field of biotechnology, particularly in the modulation of HEXIM1 expression. With a total of 5 patents to her name, her work has implications for cancer and HIV research.

Latest Patents

Monica's latest patents include innovative methods for modulating HEXIM1 expression. One of her notable patents describes a method of inducing HEXIM1 expression in cells, which involves administering a specific compound and its pharmaceutically acceptable salts. Another patent focuses on the potency of Hexamethylene bis-acetamide (HMBA) derivatives that induce HEXIM1 in cancer cells. This work also discusses the optimization of symmetrical and unsymmetrical HMBA analogs, highlighting their potential in cancer and HIV cell differentiation.

Career Highlights

Throughout her career, Monica has worked with esteemed institutions such as Case Western Reserve University and Cleveland State University. Her research has garnered attention for its innovative approaches to complex biological challenges.

Collaborations

Monica has collaborated with notable colleagues, including Bin Su and Amelia Sutton, further enhancing her research endeavors and contributions to the scientific community.

Conclusion

Monica M Montano's work in modulating HEXIM1 expression showcases her dedication to advancing biotechnology. Her patents and collaborations reflect her commitment to addressing critical health issues, particularly in cancer and HIV research.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…